Nael M Mostafa Selected Research

Nael M Mostafa Research Topics

Disease

9	Pain (Aches) 04/2024 - 08/2016
8	Endometriosis 04/2024 - 10/2018
8	Leiomyoma (Uterine Fibroids) 04/2024 - 10/2018
7	Menorrhagia 04/2024 - 10/2018
7	Crohn Disease (Crohn's Disease) 01/2023 - 11/2014
5	Ulcerative Colitis 01/2023 - 02/2014
3	Body Weight (Weight, Body) 11/2022 - 07/2014
3	Hidradenitis Suppurativa 01/2020 - 08/2016
2	Rheumatoid Arthritis 10/2023 - 01/2018
2	Bone Resorption 01/2021 - 11/2020
2	Neoplasms (Cancer) 04/2015 - 09/2014
1	Chronic Hepatitis C 04/2024
1	Virus Diseases (Viral Diseases) 04/2024
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2023
1	Hepatitis C 08/2023
1	Osteoporotic Fractures 12/2022
1	Bone Fractures (Bone Fracture) 12/2022
1	Inflammation (Inflammations) 01/2022
1	HIV Infections (HIV Infection) 12/2021
1	Dysmenorrhea (Menstrual Pain) 01/2020
1	Pelvic Pain 01/2020
1	Infections 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Nasopharyngitis 01/2018
1	Edema (Dropsy) 01/2018
1	Ankylosing Spondylitis 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Albuminuria 01/2018
1	Non-Radiographic Axial Spondyloarthritis 01/2018
1	Axial Spondyloarthritis 01/2018
1	Hypokalemia 04/2015
1	Hyponatremia 04/2015
1	Fatigue 04/2015
1	Nausea 04/2015
1	Brain Neoplasms (Brain Tumor) 04/2015
1	Precocious Puberty 07/2014
1	Hematologic Neoplasms (Hematological Malignancy) 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

15	Adalimumab (Humira)FDA Link 01/2023 - 02/2014
10	elagolixIBA 04/2024 - 10/2018
7	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 04/2024 - 10/2018
4	Norethindrone Acetate (Norlutate)FDA LinkGeneric 12/2022 - 01/2020
4	Estradiol (Delestrogen)FDA LinkGeneric 12/2022 - 01/2020
3	veliparibIBA 04/2015 - 05/2014
2	glecaprevir and pibrentasvirIBA 04/2024 - 08/2023
2	Peptides (Polypeptides)IBA 01/2022 - 10/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020 - 10/2018
2	AtrasentanIBA 01/2018 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016 - 02/2014
2	Leuprolide (Lupron)FDA LinkGeneric 07/2014 - 01/2014
1	TabletsIBA 04/2024
1	Capsules (Microcapsules)IBA 04/2024
1	Fentanyl (Sublimaze)FDA LinkGeneric 08/2023
1	AnionsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Lopinavir FDA Link 12/2021
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Ritonavir (Norvir)FDA Link 12/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	CalciumIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	ProcollagenIBA 01/2021
1	GonadotropinsIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	HS 37IBA 01/2018
1	SodiumIBA 01/2018
1	CreatinineIBA 01/2018
1	AlbuminsIBA 01/2018
1	Endothelin A ReceptorIBA 01/2018
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 07/2014
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 07/2014
1	Temozolomide (Temodar)FDA LinkGeneric 05/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2014
1	EnzymesIBA 05/2014
1	Monoclonal AntibodiesIBA 02/2014

Therapy/Procedure

10	Therapeutics 10/2023 - 04/2016
1	Biological Therapy 01/2022
1	Duration of Therapy 01/2021
1	Radiotherapy 04/2015